Update on the role of brentuximab vedotin in classical Hodgkin lymphoma

Therapeutic Advances in Hematology
Sarah Tomassetti, Alex F Herrera

Abstract

Brentuximab vedotin (BV) is an effective and well-tolerated treatment for patients with classical Hodgkin lymphoma (HL). It was initially approved by the US FDA for the treatment of HL after failure of autologous hematopoietic stem cell transplant (autoHSCT) or after failure of at least two prior lines of multiagent chemotherapy in patients who are not transplant candidates, and then subsequently, as consolidation therapy after autoHSCT in patients who are at high risk for relapse. However, the role of BV in the treatment of HL is evolving. BV has shown promising efficacy as a salvage treatment in the second-line setting prior to autoHSCT. Most recently, the ECHELON-1 trial demonstrated that BV combined with AVD for the treatment of newly diagnosed advanced stage HL improved modified progression-free survival (mPFS) compared with standard ABVD. Based on these results, the US FDA has approved BV as part of the initial treatment of advanced stage HL. With the approval of BV as front-line therapy, depending on how widely the use of BV plus AVD is adopted, the role of BV in the treatment of patients with relapsed or refractory (rel/ref) HL may need to be redefined. BV retreatment can be effective, and studies of rational BV-based c...Continue Reading

References

Jun 13, 2003·The New England Journal of Medicine·Volker DiehlUNKNOWN German Hodgkin's Lymphoma Study Group
Sep 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas Younes, Marshall E Kadin
Jun 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gianni BonadonnaPinuccia Valagussa
Nov 20, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Rueda DomínguezE Alba
Mar 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A SuredaUNKNOWN Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea Cooperative Group
Nov 7, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Navneet S MajhailLinda J Burns
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas EngertMarkus Löffler
Sep 8, 2010·The New England Journal of Medicine·James O Armitage
Nov 5, 2010·The New England Journal of Medicine·Anas YounesAndres Forero-Torres
Nov 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michelle A FanaleNancy L Bartlett
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas YounesRobert Chen
Jan 12, 2013·Pharmacotherapy·Ashley M NewlandDenise K Lowe
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Mar 20, 2014·Journal of Hematology & Oncology·Nancy L BartlettAndres Forero-Torres
Apr 23, 2015·The New England Journal of Medicine·John RadfordSally Barrington
Jun 23, 2016·The New England Journal of Medicine·Peter JohnsonSally Barrington
Aug 16, 2016·Blood·Ramón García-Sanz
Dec 12, 2017·The New England Journal of Medicine·Joseph M ConnorsUNKNOWN ECHELON-1 Study Group
Dec 23, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A F HerreraR Chen

❮ Previous
Next ❯

Citations

Jun 20, 2019·Frontiers in Oncology·Stefania CrisciAntonio Pinto

❮ Previous
Next ❯

Methods Mentioned

BETA
ICE

Clinical Trials Mentioned

NCT02661503
NCT02758717
NCT03013933

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bacterial Vaginosis

Bacterial vaginosis can increase the risk of sexually transmitted infections and in rare cases lead to pelvic inflammatory diseases. Discover the latest research on Bacterial Vaginosis here.